TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06271265: Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Sponsor: Pacira Pharmaceuticals, Inc · Phase: PHASE1 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 48 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$609,552

Rescue Site Savings

+$406,368

Unlock Full NCT06271265 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06271265 Rescue Dossier →